In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits.

Augmentin (Beecham Laboratories, Bristol, Tenn.), a combination drug consisting of two parts amoxicillin to one part clavulanic acid and a potent beta-lactamase inhibitor, was evaluated in vitro in comparison with ampicillin or amoxicillin or both for its inhibitory and bactericidal activities again...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Fuchs, P C, Barry, A L, Thornsberry, C, Gavan, T L, Jones, R N
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1983
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185100/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6625554/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.24.1.31
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!